Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol

Genetically predicted Lp(a) is positively associated with coronary plaque severity independent of LDL-C, consistent with Lp(a) promoting atherogenesis. However, the effects of Lp(a) may be greater for progression of plaque to obstructive disease than for the initial development of non-obstructive plaque. A limitation of this study is that Lp(a) was estimated using genetic markers and could not be directly assayed nor could apo(a) isoform size.

Authors

Institutions

Publication Details

Journal
European Journal of Preventive Cardiology
Published
2024-08-19
DOI
https://doi.org/10.1093/eurjpc/zwae271
Citations
14
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
8.02

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol

Peter W.F. Wilson, Sunil K. Ahuja, Themistocles L. Assimes, Lori Churby et al.
14 citations
European Journal of Preventive Cardiology
Lipoproteins and Cardiovascular Health
8.02
article

Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol

Peter W.F. Wilson, Sunil K. Ahuja, Themistocles L. Assimes, Lori Churby, Luis E. Selva, Michael E. Matheny, F. A. Gesek, Jessica V. Brewer, Ana Palacio, Maureen Murdoch, Kristin Mattocks, Samuel M. Aguayo, Peter S. Liang, Agnes Wallbom, Blake Thomson, Robin A. Hurley, Disha Sharma, Zuhair K. Ballas, X. Michelle Androulakis, Pran Iruvanti, Paul N. Meyer, Sujata Bhushan, Scott L. DuVall, Jennifer Greco, Scott Kinlay, Samuel Poon, Sumitra Muralidhar, Jack Lichy, Olaoluwa O. Okusaga, Julie Ann Lynch, Kelly Cho, Jonathan P. Moorman, Jennifer E. Deen, Shiuh‐Wen Luoh, Jon Klein, Louis J. Dell’Italia, Jeff Whittle, Salvador Gutierrez, Rose D. L. Huang, Mark B. Hamner, Richard J. Servatius, Shahpoor Alex Shayan, Saiju Pyarajan, Emily Potter, Philip S. Tsao, Brady M. Stephens, Elizabeth R. Hauser, Suthat Liangpunsakul, John B. Harley, Todd Gress, Neeraj Tandon, Edward J. Boyko, Amy M. Kilbourne, Elisabeth Mates, Patrick J. Strollo, Michael Rauchman, Kimberly Hammer, Gerardo Villareal, L. Christine Faulk, Jean C. Beckham, Darshana Jhala, Henry R. Kranzler, Jennifer Moser, Timothy R. Morgan, Stacey B. Whitbourne, Mary T. Brophy, Michael G. Levin, Samir Gupta, Daryl Fujii, Shoa L. Clarke, Mary A. Whooley, David Cohen, Austin T. Hilliard, Joseph Fayad, Saib Gappy, Peruvemba Sriram, Kathrina Alexander, Frank J. Jacono, Satish Sharma, Prakash Balasubramanian, James E. Norton, J. Michael Gaziano, Michael Godschalk, River Smith, Michael Landry, Stephen Mastorides, Allison E. Williams, Kris Ann Oursler, Shing Shing Yeh, Junzhe Xu, John M. Wells, Dave Oslin, Ronnie Marrache, Jessica Walsh, Charles S. Mahan, Sumitra Muralidha
article en
14 citations

Abstract

Genetically predicted Lp(a) is positively associated with coronary plaque severity independent of LDL-C, consistent with Lp(a) promoting atherogenesis. However, the effects of Lp(a) may be greater for progression of plaque to obstructive disease than for the initial development of non-obstructive plaque. A limitation of this study is that Lp(a) was estimated using genetic markers and could not be directly assayed nor could apo(a) isoform size.

European Journal of Preventive CardiologyVol. 32(2)
VA Palo Alto Health Care System (US), VA Boston Healthcare System (US), VA Salt Lake City Healthcare System (US), Philadelphia VA Medical Center (US), Stanford Medicine (US), University of Pennsylvania (US), Stanford University (US)
U.S. Department of Veterans Affairs, AstraZeneca, Office of Research and Development, Alnylam Pharmaceuticals, Celgene, Georgia Clinical and Translational Science Alliance, Astellas Pharma, National Institutes of Health, Janssen Pharmaceuticals
Good health and well-being
Openalex Percentile: Top 2%
Lipoproteins and Cardiovascular Health
8.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.